Mumbai: Drug-maker Sun Pharmaceutical Industries gained over 3% on the bourses on Monday after the company reported 19% growth in net profit to Rs598 crore for the quarter ended 30 September.

Sun Pharma CMD Dilip Shanghvi. File photo

The drugmaker’s scrip was also the top gainer among the Sensex-30 blue-chips in morning trade.

Sun Pharmaceutical Industries has reported 19% growth in net profit to Rs598 crore for the quarter ended 30 September on account of robust performance across its businesses.

In the corresponding year-ago period, the company had posted a net profit of Rs503.65 crore.

On a standalone basis, Sun Pharma’s net profit increased to Rs437.55 crore in the second quarter ended 30 September from Rs345.72 crore in the year-ago period.

Close